Prasad Wealth Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Prasad Wealth Partners's BIIB Position: Q3 2026 in Review
Prasad Wealth Partners increased its Biogen (BIIB) stake by 7.1% in Q3 2026, buying an estimated $21.8K and bringing the position to 1,553 shares worth $351K. The position accounts for 0.08% of the portfolio, ranked #117.
Prasad Wealth Partners first reported a position in BIIB in Q4 2024 and has held it in 6 quarters since. 620 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Prasad Wealth Partners held 1,553 shares of Biogen worth $351K as of Q3 2026.
- Prasad Wealth Partners bought 103 Biogen shares in Q3 2026, an estimated $21.8K.
- Biogen made up 0.08% of Prasad Wealth Partners's portfolio in Q3 2026, its #117 holding.
- Prasad Wealth Partners first reported a position in Biogen in Q4 2024 and has held it in 6 quarters since.
- 620 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Prasad Wealth Partners's 13F filing for Q3 2026, filed 10 Nov 2026.